National comparative audit of blood use in elective primary unilateral total hip replacement surgery in the UK

Annals of the Royal College of Surgeons of England

Volumn 91, Issue 7, 2009, Pages 599-605

  Boralessa, H ^a   Goldhill, D R ^b   Tucker, K ^c   Mortimer, A J ^d   Grant Casey, J ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^c NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^d MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Blood transfusion; Orthopaedic surgery; Total hip replacement

Indexed keywords

HEMOGLOBIN;

ARTICLE; BLOOD TRANSFUSION; CLINICAL TRIAL; ELECTIVE SURGERY; HIP ARTHROPLASTY; HUMAN; MEDICAL AUDIT; MULTICENTER STUDY; NATIONAL HEALTH SERVICE; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PREOPERATIVE PERIOD; STANDARD; UNITED KINGDOM; UTILIZATION REVIEW;

ARTHROPLASTY, REPLACEMENT, HIP; BLOOD TRANSFUSION; GREAT BRITAIN; HEMOGLOBINS; HUMANS; MEDICAL AUDIT; PERIOPERATIVE CARE; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PREOPERATIVE PERIOD; STATE MEDICINE; SURGICAL PROCEDURES, ELECTIVE;

EID: 77956086501     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/003588409X432464     Document Type: Article

References (43)

1. Williamson LM, Lowe S, Love EM, Cohen H, Soldan K, McClelland DB et al. Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BMJ 1999;319:16-9.
2. Goodnough LT. Risks of blood transfusion. Crit Care Med 2003;31: S678-86.
3. Taylor RW, Manganaro L, O'Brien J, Trottier SJ, Parkar N, Veremakis C. Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient. Crit Care Med 2002;30:2249-54.
4. Hill GE, Frawley WH, Griffith KE, Forestner JE, Minei JP. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma 2003;54:908-14.
5. Weber EW, Slappendel R, Prins MH, van der Schaaf DB, Durieux ME, Strumper D. Perioperative blood transfusions and delayed wound healing after hip replacement surgery: effects on duration of hospitalization. Anesth Analg 2005;100:1416-21.
6. Stanworth SJ, Cockburn HA, Boralessa H, Contreras M. Which groups of patients are transfused? A study of red cell usage in London and southeast England. Vox Sang 2002;83:352-7.
7. Rosencher N, Kerkkamp HE, Macheras G, Munuera LM, Menichella G, Barton DM et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003;43:459-69.
8. Gombotz H, Rehak PH, Shander A, Hofmann A. Blood use in elective surgery: the Austrian benchmark study. Transfusion 2007;47:1468-80.
9. Young SW, Marsh DJ, Akhavani MA, Walker CG, Skinner JA. Attitudes to blood transfusion post arthroplasty surgery in the United Kingdom: a national survey. Int Orthop 2008;32:325-9.
10. Pierson JL, Hannon TJ, Earles DR. A blood-conservation algorithm to reduce blood transfusions after total hip and knee arthroplasty. J Bone Joint Surg Am 2004;86:1512-8.
11. Helm AT, Karski MT, Parsons SJ, Sampath JS, Bale RS. A strategy for reducing blood-transfusion requirements in elective orthopaedic surgery. Audit of an algorithm for arthroplasty of the lower limb. J Bone Joint Surg Br 2003;85:484-9.
12. Muller U, Exadaktylos A, Roeder C, Pisan M, Eggli S, Juni P. Effect of a flow chart on use of blood transfusions in primary total hip and knee replacement: prospective before and after study. BMJ 2004;328:934-8.
13. Martinez V, Monsaingeon-Lion A, Cherif K, Judet T, Chauvin M, Fletcher D. Transfusion strategy for primary knee and hip arthroplasty: impact of an algorithm to lower transfusion rates and hospital costs. Br J Anaesth 2007;99:794-800.
14. Wong CJ, Vandervoort MK, Vandervoort SL, Donner A, Zou G, MacDonald JK et al. A cluster-randomized controlled trial of a blood conservation algorithm in patients undergoing total hip joint arthroplasty. Transfusion 2007;47:832-41.
15. Aderinto J, Brenkel IJ. Pre-operative predictors of the requirement for blood transfusion following total hip replacement. J Bone Joint Surg Br 2004;86:970-3.
16. Chief Medical Officer. Better Blood Transfusion. Health Service Circular 2002/009.
17. The Association of Anaesthetists of Great Britain & Ireland. Red Cell Transfusion. September 2001.
18. British Orthopaedic Association. Blood Conservation in Elective Orthopaedic Surgery. April 2005.
19. Vacanti CJ, VanHouten RJ, Hill RC. A statistical analysis of the relationship of physical status to postoperative mortality in 68, 388 cases. Anesth Analg 1970;49:564-6.
20. Boralessa H, Cockburn H, Casbard A, Contreras M. Review of transfusion practice in orthopaedic surgery. Curr Orthop 2004;18:126-34.
21. Goodnough LT, Shander A, Spivak JL, Waters JH, Friedman AJ, Carson JL et al. Detection, evaluation, and management of anemia in the elective surgical patient. Anesth Analg 2005;101:1858-61.
22. Saleh E, McClelland DB, Hay A, Semple D, Walsh TS. Prevalence of anaemia before major joint arthroplasty and the potential impact of preoperative investigation and correction on perioperative blood transfusions. Br J Anaesth 2007;99:801-8.
23. Carson JL, Duff A, Poses RM, Berlin JA, Spence RK, Trout R et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996;348:1055-60.
24. Keating EM, Meding JB. Perioperative blood management practices in elective orthopaedic surgery. J Am Acad Orthop Surg 2002;10:393-400.
25. Slappendel R, Dirksen R, Weber EW, van der Schaaf DB. An algorithm to reduce allogenic red blood cell transfusions for major orthopedic surgery. Acta Orthop Scand 2003;74:569-75.
26. Feagan BG, Wong CJ, Kirkley A, Johnston DW, Smith FC, Whitsitt P et al. Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial. Ann Intern Med 2000;133:845-54.
27. Weber EW, Slappendel R, Hémon Y, Mähler S, Dalén T, Rouwet E et al. Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST). Eur J Anaesthesiol 2005;22:249-57.
28. Laupacis A, Fergusson D. Erythropoietin to minimize perioperative blood transfusion: a systematic review of randomized trials. The International Study of Peri-operative Transfusion (ISPOT) Investigators. Transfus Med 1998;8:309-17.
29. Slappendel R, Weber EW, Benraad B, Dirksen R, Bugter ML. Does ibuprofen increase perioperative blood loss during hip arthroplasty? Eur J Anaesthesiol 2002;19:829-31.
30. Weber EW, Slappendel R, Durieux ME, Dirksen R, van der HH, Spruit M. COX2 selectivity of non-steroidal anti-inflammatory drugs and perioperative blood loss in hip surgery. A randomized comparison of indomethacin and meloxicam. Eur J Anaesthesiol 2003;20:963-6.
31. Oh JJ, Robon MJ, Akers WS. Optimizing antiplatelet and anticoagulant agents in the perioperative orthopedic surgery patient. Orthopedics 2005;28:453-8.
32. Hiippala ST, Strid LJ, Wennerstrand MI, Arvela JV, Niemelä HM, Mäntylä SK et al. Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesth Analg 1997;84:839-44.
33. Schmied H, Kurz A, Sessler DI, Kozek S, Reiter A. Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty. Lancet 1996;347:289-92.
34. Winkler M, Akca O, Birkenberg B, Hetz H, Scheck T, Arkiliç CF et al. Aggressive warming reduces blood loss during hip arthroplasty. Anesth Analg 2000;91:978-84.
35. Carson JL, Terrin ML, Jay M. Anemia and postoperative rehabilitation. Can J Anaesth 2003;50: S60-4.
36. Halm EA, Wang JJ, Boockvar K, Penrod J, Silberzweig SB, Magaziner J et al. The effect of perioperative anemia on clinical and functional outcomes in patients with hip fracture. J Orthop Trauma 2004;18:369-74.
37. Lawrence VA, Silverstein JH, Cornell JE, Pederson T, Noveck H, Carson JL. Higher Hb level is associated with better early functional recovery after hip fracture repair. Transfusion 2003;43:1717-22.
38. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999;340:409-17.
39. Carson JL, Duff A, Berlin JA, Lawrence VA, Poses RM, Huber EC et al. Perioperative blood transfusion and postoperative mortality. JAMA 1998;279:199-205. (Pubitemid 28133781)
40. Grover M, Talwalkar S, Casbard A, Boralessa H, Contreras M, Boralessa H et al. Silent myocardial ischaemia and haemoglobin concentration: a randomized controlled trial of transfusion strategy in lower limb arthroplasty. Vox Sang 2006;90:105-12.
41. Wells AW, Mounter PJ, Chapman CE, Stainsby D, Wallis JP. Where does blood go? Prospective observational study of red cell transfusion in north England. BMJ 2002;325:803-6.
42. Ma M, Eckert K, Ralley F, A retrospective study evaluating single unit red blood cell transfusions in reducing allogeneic exposure. Transfus Med 2005;15:307-12.
43. Murphy MF, Wallington TB, Kelsey P, Boulton F, Bruce M, Cohen H et al.; British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the clinical use of red cell transfusions. Br J Haematol 2001;112:1-10.